Intermittent blood pressure control: Potential consequences for outcome

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. C, 1999, Pages

  Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

ACE inhibitors; Beta blockers; Calcium channel blockers; Hypertension; Prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; RISK FACTORS;

EID: 0033128598     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Verdecchia P, Porcellati C, Shillaci G, Borgioni C, Ciucci A, Battistelli M. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
2. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998;16:971-5.
3. Leenen FHH. Increased risk attributed to left ventricular hypertrophy in hypertension. Curr Opin Cardiol 1996;11:464-70.
4. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986;4:141-56.
5. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995;13:1091-5.
6. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattabigio R, Zampi I. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
7. Jennings GL, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: Hansson L, Birkenhager WH, eds. Handbook for Hypertension: Assessment of Hypertensive Organ Damage. Amsterdam: Elsevier, 1997:184-223.
8. Joffres MR, Ghadirian P, Fodor G, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102.
9. Leenen FHH. Dihydropyridine calcium antagonists and sympathetic activity: relevance to cardiovascular morbidity and mortality. In: Epstein EM, ed. Calcium Antagonists in Clinical Medicine, 2nd edn. Philadelphia: Hanley Belfus Inc, 1998:527-55.